StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Gilead Sciences (GILD) PT Raised to $86 at RBC Capital Ahead of ESMO Conference
September 18, 2020 6:48 AM
RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $86.00 (from $82.00) after the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change